OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to the Hon. Stephen Ostroff, Acting Commissioner, U.S. Food and Drug Administration - FDA Review of Decision to Prescribe OxyContin to Children

Letter

Date: Sept. 18, 2015
Location: Washington, DC
Issues: Minors and Children Health and Health Care

Only available in PDF format, please see source to view document.


Source
arrow_upward